ARCHIVES

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Launches NCORP with 53 Grants Totaling $465 Million

August 8, 2014

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

Trials Approved by NCI CTEP For the Month of April

April 27, 2012